top of page

HEMEMICS

BIOTECHNOLOGIES, INC.

Latest News

December 9th, 2025

Hememics' ESAP™ Platform Validated by KanPro Research, Securing Commercial Trial Order to Combat $1 Billion Antibody-Reproducibility Crisis

June 8th, 2023

Hememics Biotechnologies, Inc and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors

June 1st, 2023

Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA

May 25th, 2023

Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

March 19th, 2025

TEDCO Invests in Hememics Biotechnologies, Inc.

June 8th, 2023

Partnership to Mass-Produce Graphene Biosensors

May 30th, 2023

Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously

July, 2020

Biosensors for On-The-Spot Tests: Two Companies Plan to Debut New Tech for COVID-19 Testing by Year's End

July 20th, 2023

Global Startup Heat Map:
Discover 5 Top Point-of-Care Diagnostics Startups

June 7th, 2023

TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc

May 25th, 2023

Hememics Biotechnologies Closes $2M Seed 2 Round

July, 2020

U. S. Cities Pilot Connected-Vehicle Tech: Enabling Conventional Vehicles to Communicate Could Save Lives Right Now

View All

bottom of page